Exact Mass: 318.0164

Exact Mass Matches: 318.0164

Found 41 metabolites which its exact mass value is equals to given mass value 318.0164, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C12H12Cl2N2O4 (318.0174)

5,6-Dichlorobenzimidazole riboside

Dichlorobenzimidazole Riboside, DRB (5,6-Dichloro-1-b-D-ribofuranosylbenzimidazole)

C12H12Cl2N2O4 (318.0174)

relative retention time with respect to 9-anthracene Carboxylic Acid is 0.751 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.745 5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].

3-Hydroxyflavone sulfate

C15H10O6S (318.0198)

DRB

5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole

C12H12Cl2N2O4 (318.0174)

5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].

2-(5-Bromo-2,3-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C12H14BBrF2O2 (318.0238)

DIETHYL 1-(2-BROMO-ETHYL)-1H-PYRAZOLE-3,5-DICARBOXYLIC ACID

C11H15BrN2O4 (318.0215)

N-(5-Iodo-4-methyl-pyridin-2-yl)-2,2-dimethyl-propionamide

C11H15IN2O (318.0229)

Bis(2,2,2-trifluoroethyl) (methoxycarbonylmethyl)phosphonate

C7H9F6O5P (318.0092)

(R)-Benzyl 2-bromo-3-phenylpropionate

C16H15BrO2 (318.0255)

3-(4-chlorophenyl)sulfanyl-2-methyl-4-nitro-1H-indole

C15H11ClN2O2S (318.023)

N-(5-IODO-3-METHYL-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE

C11H15IN2O (318.0229)

2-(2-Bromo-3,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C12H14BBrF2O2 (318.0238)

4-Bromo-2,2-diphenylbutyric acid

C16H15BrO2 (318.0255)

4-(Benzyloxy)-2-bromopropiophenone

C16H15BrO2 (318.0255)

dimethyl octafluoroadipate

C8H6F8O4 (318.0138)

4-(BENZO[B]THIOPHENE-3-SULFONYL)-PIPERAZINE HYDROCHLORIDE

C12H15ClN2O2S2 (318.0263)

4-BROMO-1,2-DIMETHYL-5-(QUINOXALIN-6-YL)-1H-PYRAZOL-3(2H)-ONE

C13H11BrN4O (318.0116)

N-(5-IODO-6-METHYL-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE

C11H15IN2O (318.0229)

Diethyl [(5-chloro-1-benzothiophen-3-yl)methyl]phosphonate

C13H16ClO3PS (318.0246)

methyl 4-tert-butyl-3-iodobenzoate

C12H15IO2 (318.0117)

4-(4-(thiophen-2-yl)thiazol-2-ylamino)-2-hydroxybenzoic acid

C14H10N2O3S2 (318.0133)

4,4-(Ethyne-1,2-diyl)diphthalic Anhydride

C18H6O6 (318.0164)

2-(4-ethyl-3-iodophenyl)-2-Methylpropanoic acid

C12H15IO2 (318.0117)

Dichlororibofuranosylbenzimidazole

5,6-Dichlorobenzimidazole riboside

C12H12Cl2N2O4 (318.0174)

D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors 5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].